Search filters

List of works by Alessandro Isidori

A diagnostic dilemma in stem cell transplantation for beta-thalassemia major: progressive loss of take or pure red cell aplasia?

scientific article published in December 2007

AML therapy in the elderly: a time for a change.

scientific article published on 7 April 2016

Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase.

scientific article published on 14 December 2006

Age influences initial dose and compliance to imatinib in chronic myeloid leukemia elderly patients but concomitant comorbidities appear to influence overall and event-free survival

All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemia

scientific article published on 01 March 2000

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.

scientific article published on December 2013

An observational study of once weekly intravenous ganciclovir as CMV prophylaxis in heavily pre-treated chronic lymphocytic leukemia patients receiving subcutaneous alemtuzumab

scientific article published on 01 December 2006

Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts

scientific article

Autologous stem cell transplantation for aggressive lymphomas.

scientific article published on 7 November 2012

Autologous transplantation of granulocyte colony-stimulating factor-primed bone marrow is effective in supporting myeloablative chemotherapy in patients with hematologic malignancies and poor peripheral blood stem cell mobilization

BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients

scientific article published on 03 August 2011

Benda-EAM prior to ASCT and renal toxicity: Much ado about nothing

scientific article published on 04 February 2019

Bendamustine, etoposide, cytarabine, melphalan, and autologous stem cell rescue produce a 72% 3-year PFS in resistant lymphoma

scientific article published on 01 November 2014

Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.

scientific article

Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia

scientific article published in May 2001

Complete clearance of Ph+ metaphases after 3 months is a very early indicator of good response to imatinib as front-line treatment in chronic myelogenous leukemia

scientific article published on 28 November 2012

Conditioning regimens in acute myeloid leukemia

scientific article published on August 2014

Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine

scientific article published on 01 June 2006

Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma

scientific article published in March 2005

Dasatinib, even at low doses, is an effective second-line therapy for chronic myeloid leukemia patients resistant or intolerant to imatinib. Results from a real life-based Italian multicenter retrospective study on 114 patients

scientific article published on December 2010

Deferasirox improves hematopoiesis after allogeneic hematopoietic SCT

scientific article published on 13 January 2014

Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a lar

scientific article published on 05 June 2018

Doxorubicin variants for hematological malignancies

scientific article published on 01 February 2011

Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients

scholarly article by Francesca Palandri et al published November 2018 in Leukemia Research

Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study

scientific article

Enteric-coated mycophenolate sodium: a new option for GHVD prophylaxis?

scientific article published on 01 April 2017

Environmental nanoparticles are significantly over-expressed in acute myeloid leukemia.

scientific article

Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients

scientific article published on 6 April 2018

Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas

scientific article

Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy

scientific article published in July 2004

High-dose therapy followed by stem cell transplantation in Hodgkin's lymphoma: past and future

scientific article published on August 2013

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome

scientific article published on 27 August 2016

Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study

scientific article published in August 2013

Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib

scientific article published on 07 June 2019

Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib

scientific article published on 04 December 2018

Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells

article

Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis

scientific article published on 20 December 2019

Liposomal daunorubicin (DaunoXome) for treatment of relapsed meningeal acute myeloid leukemia.

scientific article published in September 2002

Long-term molecular complete remission with IFN-alpha in Ph+ adult acute lymphoid leukemia patients

scientific article published on 14 February 2008

Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?

scientific article published in August 2004

Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study

scientific article

Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients

scientific article published on 20 January 2014

Microdose alpha-interferon shows clinical and antiangiogenic effect in extramedullary myeloid tumor: a case report.

scientific article published in May 2003

Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia

scientific article

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

scientific article published on April 2007

Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely.

scientific article

Myeloid Sarcoma: The Clinician's Point of View

scientific article published on 27 April 2011

Nanocarriers targeting cancer stem cells: how to help drugs to find their way home

scientific article published on 01 January 2015

Nanomedicine strategies for hematological malignancies: what is next?

scientific article

Nonpegylated liposomal doxorubicin in the treatment of B-cell non-Hodgkin's lymphoma: where we stand.

scientific article published on March 2009

Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning

scientific article

Nucleofection is an efficient nonviral transfection technique for human bone marrow-derived mesenchymal stem cells

scientific article

PBSC mobilization in patients with autoimmune diseases: what's next

scientific article published on 01 July 2016

Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling.

scientific article published on 23 May 2017

Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice

scientific article published on 19 April 2018

R-COMP 21 for frail elderly patients with aggressive B-cell non-Hodgkin lymphoma: a pilot study

scientific article published in June 2008

RISK FACTORS FOR PROGRESSION TO BLAST PHASE AND OUTCOME IN 589 PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB: REAL WORLD DATA

scientific article published on 09 April 2020

Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state

scientific article published on 01 January 2002

Resistant chronic myeloid leukemia beyond tyrosine-kinase inhibitor therapy: which role for omacetaxine?

scientific article published on 23 October 2013

Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis

scientific article published on 07 January 2021

Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients

scientific article published on 16 July 2018

SARS-CoV-2 impact in a community-based hematological ward in an Italian Red Zone

scientific article published on 13 June 2020

SNPs array karyotyping reveals a novel recurrent 20p13 amplification in primary myelofibrosis

scientific article

Second primary malignancy in myelofibrosis patients treated with ruxolitinib

scientific article published on 21 November 2020

Self-Awareness Training Associated with Personality Traits and Sex: A Pilot Study ⬇️

scientific article published on August 1, 2010

Sequential combination of thalidomide and erythropoietin determines transfusion independence and disease control in idiopathic myelofibrosis previously insensitive to both drugs used as single agents.

scientific article published in August 2003

Stem cell mobilization and collection in patients with liver cirrhosis

scientific article published on 29 February 2008

Stem cell mobilization: the other side of the coin: commentary on the current status of stem cell mobilization

scientific article published on 01 September 2010

Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients

Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scans

scientific article published on 01 March 2007

The hOCT1 and ABCB1 polymorphisms do not influence the pharmacodynamics of nilotinib in chronic myeloid leukemia.

scientific article

The incidence of Pneumocystis jirovecii pneumonia is not higher in patients receiving dose-dense therapy with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine, and prednisolone and adequate Pneumocystis jirovecii pneumon

scientific article published on 11 November 2010

The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply).

scientific article published on April 2011

The prevention of alemtuzumab-induced cytomegalovirus reactivation: still a matter of debate. An update from Pesaro experience with once weekly intravenous ganciclovir.

scientific article published in February 2009

The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment

scientific article published on 16 September 2014

Update on the role of autologous hematopoietic stem cell transplantation in multiple myeloma

scientific article published on 5 November 2012

Paulina is supported by:

About Paulina

Help